| Year |
Citation |
Score |
| 2019 |
Chen CY, Chou FS, Wang PS. Live-cell Migration Assays to Study Motility of Neural andGlial (Oligodendrocyte) Progenitor Cells. Bio-Protocol. 9: e3275. PMID 33654792 DOI: 10.21769/BioProtoc.3275 |
0.337 |
|
| 2019 |
Chen C, Chou F, Wang P. Live-cell Migration Assays to Study Motility of Neural and Glial (Oligodendrocyte) Progenitor Cells Bio-Protocol. 9. DOI: 10.21769/bioprotoc.3275 |
0.304 |
|
| 2018 |
Wunderlich M, Chou FS, Sexton C, Presicce P, Chougnet CA, Aliberti J, Mulloy JC. Improved multilineage human hematopoietic reconstitution and function in NSGS mice. Plos One. 13: e0209034. PMID 30540841 DOI: 10.1371/Journal.Pone.0209034 |
0.647 |
|
| 2016 |
Lin S, Wei J, Wunderlich M, Chou FS, Mulloy JC. Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation. Oncotarget. PMID 27509060 DOI: 10.18632/Oncotarget.11093 |
0.67 |
|
| 2016 |
Wang PS, Chou FS, Ramachandran S, Xia S, Chen HY, Guo F, Suraneni P, Maher B, Li R. Crucial roles of the Arp2/3 complex during mammalian corticogenesis. Development (Cambridge, England). PMID 27385014 DOI: 10.1242/Jcs.195982 |
0.331 |
|
| 2013 |
Wunderlich M, Mizukawa B, Chou FS, Sexton C, Shrestha M, Saunthararajah Y, Mulloy JC. AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model. Blood. 121: e90-7. PMID 23349390 DOI: 10.1182/Blood-2012-10-464677 |
0.63 |
|
| 2012 |
Chou FS, Griesinger A, Wunderlich M, Lin S, Link KA, Shrestha M, Goyama S, Mizukawa B, Shen S, Marcucci G, Mulloy JC. The thrombopoietin/MPL/Bcl-xL pathway is essential for survival and self-renewal in human preleukemia induced by AML1-ETO. Blood. 120: 709-19. PMID 22337712 DOI: 10.1182/Blood-2012-01-403212 |
0.646 |
|
| 2012 |
Maiques-Diaz A, Chou FS, Wunderlich M, Gómez-López G, Jacinto FV, Rodriguez-Perales S, Larrayoz MJ, Calasanz MJ, Mulloy JC, Cigudosa JC, Alvarez S. Chromatin modifications induced by the AML1-ETO fusion protein reversibly silence its genomic targets through AML1 and Sp1 binding motifs. Leukemia. 26: 1329-37. PMID 22289984 DOI: 10.1182/Blood.V118.21.2422.2422 |
0.576 |
|
| 2011 |
Mizukawa B, Wei J, Shrestha M, Wunderlich M, Chou FS, Griesinger A, Harris CE, Kumar AR, Zheng Y, Williams DA, Mulloy JC. Inhibition of Rac GTPase signaling and downstream prosurvival Bcl-2 proteins as combination targeted therapy in MLL-AF9 leukemia. Blood. 118: 5235-45. PMID 21940819 DOI: 10.1182/Blood-2011-04-351817 |
0.645 |
|
| 2011 |
Sipes NS, Feng Y, Guo F, Lee HO, Chou FS, Cheng J, Mulloy J, Zheng Y. Cdc42 regulates extracellular matrix remodeling in three dimensions. The Journal of Biological Chemistry. 286: 36469-77. PMID 21880728 DOI: 10.1074/Jbc.M111.283176 |
0.565 |
|
| 2011 |
Chou FS, Mulloy JC. The thrombopoietin/MPL pathway in hematopoiesis and leukemogenesis. Journal of Cellular Biochemistry. 112: 1491-8. PMID 21360575 DOI: 10.1002/Jcb.23089 |
0.618 |
|
| 2011 |
Chou FS, Wunderlich M, Griesinger A, Mulloy JC. N-Ras(G12D) induces features of stepwise transformation in preleukemic human umbilical cord blood cultures expressing the AML1-ETO fusion gene. Blood. 117: 2237-40. PMID 21200020 DOI: 10.1182/Blood-2010-01-264119 |
0.604 |
|
| 2011 |
Mizukawa B, Shrestha M, Wunderlich M, Chou F, Griesinger A, Kumar A, Zheng Y, Williams DA, Mulloy JC. Rac GTPase Survival Signaling Through Anti-Apoptotic Bcl-2 Proteins Reveals a Target for Combination Therapy in MLL-AF9 Acute Myeloid Leukemia Blood. 118: 1536-1536. DOI: 10.1182/Blood.V118.21.1536.1536 |
0.702 |
|
| 2010 |
Wunderlich M, Chou FS, Link KA, Mizukawa B, Perry RL, Carroll M, Mulloy JC. AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3. Leukemia. 24: 1785-8. PMID 20686503 DOI: 10.1038/leu.2010.158 |
0.533 |
|
| 2010 |
Link KA, Chou FS, Mulloy JC. Core binding factor at the crossroads: determining the fate of the HSC. Journal of Cellular Physiology. 222: 50-6. PMID 19813271 DOI: 10.1002/Jcp.21950 |
0.606 |
|
| 2010 |
Wunderlich M, Presicce P, Chou F, Chougnet C, Aliberti J, Mulloy JC. Enhanced Myeloid and T Cell Development and Improved Functionality of Cord Blood Xenografts In the NSGS Mouse. Blood. 116: 3729-3729. DOI: 10.1182/Blood.V116.21.3729.3729 |
0.657 |
|
| 2010 |
Wunderlich M, Chou F, Shrestha M, Mizukawa B, Mulloy JC. Adaptation of a Xenograft AML Model to Evaluate Chemotherapeutic Efficacy In Vivo Blood. 116: 3304-3304. DOI: 10.1182/Blood.V116.21.3304.3304 |
0.654 |
|
| 2009 |
Chou F, Wunderlich M, Mulloy JC. Bcl-Xl Mitigates p53 Activity in AML1-ETO-Expressing Human Hematopoietic Cells. Blood. 114: 387-387. DOI: 10.1182/Blood.V114.22.387.387 |
0.693 |
|
| 2009 |
Wunderlich M, Chou F, Mizukawa B, Link KA, Mulloy JC. A New Immunodeficient Mouse Strain, NOD/SCID IL2Rγ−/− SGM3, Promotes Enhanced Human Hematopoietic Cell Xenografts with a Robust T Cell Component. Blood. 114: 3524-3524. DOI: 10.1182/Blood.V114.22.3524.3524 |
0.657 |
|
| 2009 |
Wunderlich M, Link KA, Chou F, Mulloy JC. Constitutive Activation of Rac GTPases Is Induced by Cooperating Mutations in a Human Model of MLL-AF9 Leukemia. Blood. 114: 2959-2959. DOI: 10.1182/Blood.V114.22.2959.2959 |
0.692 |
|
| 2009 |
Mizukawa B, Wei J, Wunderlich M, Chou F, Zheng Y, Williams DA, Mulloy JC. Bcl-XL Is a Critical Mediator of Rac Signaling in MLL-AF9-Induced Acute Myeloid Leukemia. Blood. 114: 1971-1971. DOI: 10.1182/Blood.V114.22.1971.1971 |
0.696 |
|
| 2009 |
Chou F, Wunderlich M, Mulloy JC. Thrombopoietin/Bcl-Xl Signaling Is Essential for the Self-Renewal Phenotypes of AML1-ETO Expressing Human Hematopoietic Cells. Blood. 114: 1424-1424. DOI: 10.1182/Blood.V114.22.1424.1424 |
0.707 |
|
| 2008 |
Krejci O, Wunderlich M, Geiger H, Chou FS, Schleimer D, Jansen M, Andreassen PR, Mulloy JC. p53 signaling in response to increased DNA damage sensitizes AML1-ETO cells to stress-induced death. Blood. 111: 2190-9. PMID 17975013 DOI: 10.1182/Blood-2007-06-093682 |
0.609 |
|
| 2008 |
Chou F, Wunderlich M, Mulloy JC. Bcl-2 Family Dysregulation in AML1-ETO-Expressing Human Hematopoietic Cells Blood. 112: 5330-5330. DOI: 10.1182/Blood.V112.11.5330.5330 |
0.681 |
|
| Show low-probability matches. |